Answers are grounded in this paper and cite their sources.
Introduction Chronic musculoskeletal pain is a leading cause of disability worldwide and is commonly managed through multimodal rehabilitation strategies. Whole-body vibration (WBV) therapy has been proposed as a complementary intervention, with potential analgesic effects mediated by neurophysiological and neuromuscular mechanisms. However, existing evidence remains inconsistent regarding its comparative effectiveness against active interventions. This systematic review and meta-analysis of randomized controlled trials aimed to evaluate the effects of WBV on chronic musculoskeletal pain and explore potential moderators of effectiveness. Methods Searches were conducted on September 5, 2025, across PubMed, Embase, CENTRAL, CINAHL, SPORTDiscus, Web of Science, LILACS, PEDro, and SciELO. Methodological quality was assessed using the PEDro scale, and the certainty of evidence was evaluated using the GRADE approach. Meta-analyses were performed using the standardized mean difference (SMD). Results Thirty-four randomized controlled trials (1,808 participants) were included; 38.2% of studies were rated as having low methodological quality according to the PEDro scale. At immediate post-intervention assessment, moderate-certainty evidence demonstrated a large but heterogeneous analgesic effect of WBV compared with inactive control conditions (SMD = −0.82; p < 0.001; I² = 76%). In contrast, no significant between-group differences were observed when WBV was compared with other active interventions (SMD = 0.11; p = 0.52; I² = 69%). Pre-specified subgroup analyses only partially explained the observed between-study heterogeneity. At follow-up, low-certainty evidence indicated a small but statistically significant effect favoring WBV over inactive controls (SMD = −0.27; p = 0.04; I² = 0%), while no differences were found relative to active comparators (SMD = 0.04; p = 0.82; I² = 0%). Half of the included studies did not report any safety data, and only 17.6% documented adverse events. Conclusion WBV therapy is associated with short-term reductions in chronic musculoskeletal pain when compared with inactive controls; however, comparisons with other active interventions showed no significant differences, although these findings remain limited by considerable heterogeneity among comparator modalities. Additionally, the safety profile of WBV remains understudied, and benefits do not appear to persist after treatment cessation. These findings suggest WBV may serve as an adjunctive modality within multimodal rehabilitation, rather than a stand-alone alternative.
No takes yet. Share an insight, caveat, or question.
Montebello et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: